Supplemental Methods: Ruxolitinib cream for discoid lupus erythematosus
收藏NIAID Data Ecosystem2026-05-02 收录
官方服务：
资源简介：
Supplemental Methods - Ruxolitinib cream for discoid lupus erythematosus: an open-label pilot study of ten subjects
应用场景：
创建时间：
2024-10-15
相关数据集
A Phase 1b Randomized Single-Center Trial of Topical Cerdulatinib (DMVT-502) in Patients with Mild-to-Moderate Atopic Dermatitis
This phase 1b, single-center, double-blind study evaluated safety, efficacy, and effect on molecular profiles of a topical Janus kinase/spleen tyrosine kinase (JAK/Syk) inhibitor, cerdulatinib gel 0.3
NIAID Data Ecosystem140
Table_1_COVID-19: High-JAKing of the Inflammatory “Flight” by Ruxolitinib to Avoid the Cytokine Storm.docx
Since SARS-CoV-2 outbreak in December 2019, world health-system has been severely impacted with increased hospitalization, Intensive-Care-Unit (ICU) access and high mortality rates, mostly due to seve
NIAID Data Ecosystem80
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Upadacitinib in Subjects With Active Ankylosing Spondylitis
The purpose of this study is to evaluate the safety and efficacy of upadacitinib in participants with active ankylosing spondylitis (AS) who have had an inadequate response to at least 2 non-steroid
DataCite Commons2025-04-01 更新30
Supplementary Material for: Darier’s Disease Successfully Treated with Tofacitinib: A Case Report
Darier’s disease (DD) is a rare autosomal dominant genodermatosis characterized by keratotic papules, predominantly affecting seborrheic areas. We report a 42-year-old woman who developed pruritic bro
NIAID Data Ecosystem80
Table_2_B Cell Signatures Distinguish Cutaneous Lupus Erythematosus Subtypes and the Presence of Systemic Disease Activity.pdf
Cutaneous lupus erythematosus (CLE) is a chronic inflammatory skin disease characterized by a diverse cadre of clinical presentations. CLE commonly occurs in patients with systemic lupus erythematosus
NIAID Data Ecosystem60
